Stock Ratios
Making an investment decision in the stock market involves a certain amount of risk, so it's important to thoroughly review a company's stock before making any decisions. Stock float, number of short positions and outstanding shares are among the many factors an investor should take into account.
valuation ratios | |
---|---|
pe ratio | -1.48 |
peg ratio | 0.00 |
price to book ratio | -7.19 |
price to sales ratio | 239.30 |
enterprise value multiple | -3.58 |
price fair value | -7.19 |
profitability ratios | |
---|---|
gross profit margin | 37.93% |
operating profit margin | -8726.72% |
pretax profit margin | -18071.55% |
net profit margin | -18071.55% |
return on assets | -193.1% |
return on equity | 172.71% |
return on capital employed | 316.05% |
liquidity ratio | |
---|---|
current ratio | 0.64 |
quick ratio | 0.62 |
cash ratio | 0.62 |
efficiency ratio | |
---|---|
days of inventory outstanding | 0.00 |
operating cycle | 204.53 |
days of payables outstanding | 0.00 |
cash conversion cycle | 204.53 |
receivables turnover | 1.78 |
payables turnover | 0.00 |
inventory turnover | 0.00 |
debt and solvency ratios | |
---|---|
debt ratio | 0.06 |
debt equity ratio | -0.15 |
long term debt to capitalization | -0.11 |
total debt to capitalization | -0.18 |
interest coverage | -2.74 |
cash flow to debt ratio | -11.66 |
cash flow ratios | |
---|---|
free cash flow per share | -2.69 |
cash per share | 3.12 |
operating cash flow per share | -2.69 |
free cash flow operating cash flow ratio | 1.00 |
cash flow coverage ratios | -11.66 |
short term coverage ratios | -32.52 |
capital expenditure coverage ratio | 0.00 |
Frequently Asked Questions
AgeX Therapeutics, Inc. (AGE) published its most recent earnings results on 14-05-2024.
An investor's main concern is the profitability ratios of a company so that they are able to understand how it performs financially. Investors are interested in finding out how effectively a business is using their cash to produce earnings, which is why return on equity (ROE) ratio is important. AgeX Therapeutics, Inc. (AMEX:AGE)'s trailing twelve months ROE is 172.71%.
The Return on Assets (ROA) ratio measures how profitable a company is relative to its total assets. AgeX Therapeutics, Inc. (AGE) currently has a ROA of -193.1%. Companies that manage their assets effectively will have greater returns, while those that do so poorly would suffer lower returns.
AGE reported a profit margin of -18071.55% in the last quarter. A company's profit margin, also known as its revenue ratio or gross profit ratio, reflects the amount of revenue that an organization earns compared to its net income. In general, a higher ratio implies greater profit, and vice versa.
Apple's current ratio, which measures its ability to pay short-term obligations, was 0.64 in the most recent quarter. The quick ratio stood at 0.62, with a Debt/Eq ratio of -0.15.